Application Nr Approved Date Route Status External Links
ANDA204065 None Oral None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Desvenlafaxine Extended-Release Tablets Are Indicated For The Treatment Of Adults With Major Depressive Disorder (Mdd) [See Clinical Studies ( 14 )] . Desvenlafaxine Extended-Release Tablets Are A Serotonin And Norepinephrine Reuptake Inhibitor (Snri) Indicated For The Treatment Of Adults With Major Depressive Disorder (Mdd) ( 1 ).

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Desvenlafaxine Succinate DESVENLAFAXINE SUCCINATE ZINC2525885

Comments